Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07468175 · ClinicalTrials.gov registry record · NA
A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT07468175 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 48 participants.
The verdict
NCT07468175, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This was a single-center, double-blinded, randomized, controlled cosmetic clinical trial to investigate the efficacy and tolerance of dark spot corrector serum and regimen skincare products when used over the course of 16 weeks by women with clinically determined moderate discrete hyperpigmentation (solar lentigines \[age spots/sun spots\]) on the global face, and self-perceived very bothersome hyperpigmentation (darkening), including spots, on the global face.
Interventions
- OTHER Cosmetic dark spot corrector serum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2025-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07468175
The ClinicalTrials.gov registry entry for NCT07468175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cosmetic dark spot corrector serum is the first listed.
NCT07468175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07468175 about?
NCT07468175 is a clinical study titled "A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation". This was a single-center, double-blinded, randomized, controlled cosmetic clinical trial to investigate the efficacy and tolerance of dark spot corrector serum and regimen skincare products when used over the course of 16 weeks by women with clinically determined moderate discrete hyperpigmentation ...
What is the current status of trial NCT07468175?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2024-10-21. Estimated completion is 2025-03-27.
What interventions are being tested in trial NCT07468175?
The interventions under investigation include: Cosmetic dark spot corrector serum (OTHER).
Who is sponsoring clinical trial NCT07468175?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.